Capricor Therapeutics (CAPR) Revenue Growth (5y) (2016 - 2024)
Capricor Therapeutics (CAPR) Revenue Growth (5y) (2016 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
723,416.35 Bn |
723,416.32 Bn |
- |
| 2 |
Belite Bio |
57,340.00 Bn |
57,340.00 Bn |
- |
| 3 |
Quantum Biopharma |
19,125.08 Bn |
19,125.08 Bn |
- |
| 4 |
Legend Biotech |
3,262.00 Bn |
3,261.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,789.67 Bn |
1,789.67 Bn |
- |
| 6 |
Evaxion A |
1,480.39 Bn |
1,480.37 Bn |
- |
| 7 |
Psyence Biomedical |
241.78 Bn |
241.78 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.54 Bn |
106.29 Bn |
2.59 Bn |
| 9 |
Abivax |
94.26 Bn |
94.26 Bn |
- |
| 10 |
Capricor Therapeutics |
1.53 Bn |
1.26 Bn |
- |
| Date | Value |
|---|
| Dec 31, 2024 |
118.77% |
| Sep 30, 2024 |
73.93% |
| Jun 30, 2024 |
57.46% |
| Mar 31, 2024 |
112.55% |
| Dec 31, 2023 |
79.53% |
| Sep 30, 2023 |
95.03% |
| Jun 30, 2023 |
57.52% |
| Mar 31, 2023 |
49.49% |
| Dec 31, 2022 |
15.07% |
| Sep 30, 2022 |
38.41% |
| Jun 30, 2021 |
-25.87% |
| Mar 31, 2021 |
-46.27% |
| Dec 31, 2020 |
-53.48% |
| Sep 30, 2020 |
-58.16% |
| Jun 30, 2020 |
-47.84% |
| Mar 31, 2020 |
-29.17% |
| Dec 31, 2019 |
15.87% |
| Sep 30, 2019 |
-32.86% |
| Jun 30, 2019 |
-17.00% |
| Mar 31, 2019 |
-26.04% |
